ArticleBMC public health2025
Impact of the COVID-19 pandemic on unfavorable tuberculosis outcomes: a comparative analysis of unhoused and general populations.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTuberculosis care has been seriously affected by the COVID-19 pandemic. Few studies have assessed the impact of the pandemic on tuberculosis outcomes in vulnerable populations. We aimed to evaluate tuberculosis outcomes before and during the pandemic in general and in unhoused populations in São Paulo, Brazil.
methodsWe performed a retrospective cohort study that compared tuberculosis outcomes between the unhoused and general populations using data from 2017 to 2019 and 2020 to 2022. Unfavorable outcomes were defined as loss to follow-up, treatment failure, death, toxicity, and resistance to drugs. Cox regression models and Kaplan‒Meier curves were used to evaluate the data.
resultsAmong 47,293 patients diagnosed with tuberculosis using the National Notifiable Diseases Information System (SINAN) between January 1, 2017, and December 31, 2021, 29,247 patients were included in our study. Patients diagnosed with TB during the pandemic were more likely to have unfavorable outcomes in the general population (hazard ratio [HR], 1.45, [95% confidence interval (CI), 1.37 to 1.55], p < 0.001), but not in the unhoused population. Patients with lost to follow-up (HR, 1.42, 95% CI 1.21-1.66, p < 0.001) or hospitalized (HR, 1.50, 95%CI 1.29-1.74, p < 0.001) were more likely to experience unfavorable outcomes in the unhoused population.
conclusionsIn conclusion, during the pandemic of COVID-19 period the tuberculosis care was not affected in the specific unhoused population but rather affected the general population in the largest city of São Paulo, Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.